|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM112683770 |
003 |
DE-627 |
005 |
20231222162258.0 |
007 |
tu |
008 |
231222s1995 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0376.xml
|
035 |
|
|
|a (DE-627)NLM112683770
|
035 |
|
|
|a (NLM)11362397
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Manesis, D A
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Thalidomide
|b an alternative therapy for treatment of apthous ulcers (canker sores)
|
264 |
|
1 |
|c 1995
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 13.06.1995
|
500 |
|
|
|a Date Revised 23.11.2016
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
650 |
|
4 |
|a Clinical Trial
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Newspaper Article
|
650 |
|
4 |
|a Randomized Controlled Trial
|
650 |
|
7 |
|a Placebos
|2 NLM
|
650 |
|
7 |
|a Thalidomide
|2 NLM
|
650 |
|
7 |
|a 4Z8R6ORS6L
|2 NLM
|
773 |
0 |
8 |
|i Enthalten in
|t STEP perspective
|d 1995
|g 7(1995), 1 vom: 21., Seite 16-7
|w (DE-627)NLM098241915
|7 nnns
|
773 |
1 |
8 |
|g volume:7
|g year:1995
|g number:1
|g day:21
|g pages:16-7
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 7
|j 1995
|e 1
|b 21
|h 16-7
|